Paragard IUD class action lawyers help injured parties establish personal injury lawsuits against Cooper Companies and affiliated medical institutions. These lawsuits address the negative side effects of Paragard IUD usage. They have so grown in number as to form class action multidistrict litigation.
Conditions that entitle a person to enter into this class action range from permanent infertility to organ punctures. If you’ve endured these conditions or similar side effects, you may be entitled to enter into the ongoing Paragard class action lawsuit.
Zanes Law attorneys can help you establish a violated duty of care addressing both the ongoing use of Paragard IUDs and Cooper Companies’ refusal to recall their product.
Developments in the Paragard Class Action Lawsuit
The class action multidistrict litigation against Cooper Companies and affiliated parties is still developing. Recently, these development have included:
- July 18, 2022 – 51 additional cases have joined the Paragard IUD docket. The multidistrict litigation judge assigned to the Paragard class action lawsuit has ordered interested plaintiffs to submit their facts sheets. Parties must also complete discovery related to their losses. All plaintiffs must submit these documents within the next 120 days. The total number of Paragard IUD cases in action at this point totals 1,246.
- June 23, 2022 – Between May 15, 2022, and June 15, 2022, 177 clients filed lawsuits against Cooper Companies citing Paragard IUD injuries as their cause. This 30-day period indicates the largest growth in Paragard IUD lawsuits since the class action multidistrict litigation opened. Discovery for all of these parties is still ongoing. No trials have been scheduled. Clients are still waiting for the facts sheets from early June to be finalized.
- June 6, 2022 – Multidistrict litigation Judge Leigh Martin May reviewed the status of Plaintiff Fact Sheets. No cases have transitioned at this time, though the body of lawsuits addressing Paragard injuries and Cooper Companies’ negligence continues to grow.